Nordnet Indexfond Europa vs Danske Invest Global Index I NOK

Nordnet Indexfond Europa vs Danske Invest Global Index I NOK

1. Nordnet Indexfond Europa

  • Security

    Nordnet Indexfond Europa ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2L82

  • Holdings

    16

  • Number of owning funds

    3

2. Danske Invest Global Index I NOK

  • Security

    Danske Invest Global Index I NOK

  • Fee

    0.29%

  • ISIN

    LU2484582676

  • Holdings

    14

  • Number of owning funds

    1

Fund Holdings

We have information about 25 holdings in Nordnet Indexfond Europa, where the largest holding is AstraZeneca (3.82), followed by Novo Nordisk (3.67) and HSBC Holdings (3.41). In comparison with Danske Invest Global Index I NOK, we have 25 holdings where Apple is the largest holding (5.09), followed by Nvidia (4.28) and Microsoft (3.93).

All Holdings

Here we compare the holdings in Nordnet Indexfond Europa and Danske Invest Global Index I NOK.

Nordnet Indexfond Europa Danske Invest Global Index I NOK
1. AstraZeneca
Sweden UK
3.82 %
1. Apple Inc
USA
5.09 %
2. Novo Nordisk ADR
Denmark
3.67 %
2. Nvidia Corp
USA
4.28 %
3. HSBC Holdings PLC
UK
3.41 %
3. Microsoft Corp
USA
3.93 %
4. Unilever Plc
UK
2.71 %
4. Amazon.com Inc
USA
2.82 %
5. TotalEnergies SE
France
2.16 %
5. Meta Platforms A
USA
2.04 %
6. Iberdrola SA
Spain
1.81 %
6. Alphabet Inc Class A
USA
1.39 %
7. RELX ADR
UK
1.74 %
7. Broadcom Inc
USA
1.25 %
8. Spotify Technology SA
Sweden
1.62 %
8. Alphabet Inc Class C
USA
1.22 %
9. Muenchener Rueckversicherungs-Gesellschaft AG
Germany
1.57 %
9. Tesla Inc
USA
1.19 %
10. Hermes International SCA
France
1.48 %
10. JP Morgan Chase & Co
USA
1.06 %
11. AXA SA
France
1.44 %
11. Eli Lilly and Co
USA
1.05 %
12. ABB Ltd
Sweden Switzerland
1.43 %
12. Berkshire Hathaway Inc Class B
USA
0.98 %
13. Intesa Sanpaolo SpA
Italy
1.38 %
13. Visa Inc
USA
0.89 %
14. National Grid Plc
UK
1.22 %
14. Mastercard Inc
USA
0.69 %
15. Enel SpA
1.21 %
-
16. Prosus NV
Netherlands
1.09 %
-

The list of fund holdings was last updated on June 5, 2025.